​
​

NeuroBo Pharmaceuticals (NRBO) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

NeuroBo Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$7.00K

0

NeuroBo Pharmaceuticals Revenue by Period

NeuroBo Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$7.00K100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31--

NeuroBo Pharmaceuticals generated $7.00K in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

NeuroBo Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$4.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31--

NeuroBo Pharmaceuticals generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

NeuroBo Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BDRXBiodexa Pharmaceuticals$381.00K$41.50K
SONNSonnet BioTherapeutics$147.81K-
VRAXVirax Biolabs Group$8.56K$76.50K
NRBONeuroBo Pharmaceuticals$7.00K-
PXMDPaxMedica--
ZURAZura Bio--
REVBRevelation Biosciences--
HILSTharimmune--
ATNF180 Life Sciences--
PHIOPhio Pharmaceuticals--
ALLRAllarity Therapeutics--
QNRXQuoin Pharmaceuticals--
KPRXKiora Pharmaceuticals--
CDIOCardio Diagnostics-$6.58K
BWVOnconetix--

NRBO Revenue FAQ

What is NeuroBo Pharmaceuticals’s yearly revenue?

NeuroBo Pharmaceuticals's yearly revenue for 2023 was $7K, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. NRBO's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is NeuroBo Pharmaceuticals’s quarterly revenue?

NeuroBo Pharmaceuticals's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). NRBO's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is NeuroBo Pharmaceuticals’s revenue growth rate?

NeuroBo Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.